| __timestamp | Bio-Techne Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 5078000000 |
| Thursday, January 1, 2015 | 119401000 | 4717000000 |
| Friday, January 1, 2016 | 140879000 | 5096000000 |
| Sunday, January 1, 2017 | 199243000 | 4986000000 |
| Monday, January 1, 2018 | 240636000 | 4214000000 |
| Tuesday, January 1, 2019 | 264359000 | 3806000000 |
| Wednesday, January 1, 2020 | 260583000 | 3671000000 |
| Friday, January 1, 2021 | 324951000 | 3528000000 |
| Saturday, January 1, 2022 | 372766000 | 3445000000 |
| Sunday, January 1, 2023 | 378378000 | 3498000000 |
| Monday, January 1, 2024 | 396826000 | 3702000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical and biotech sectors, effective cost management is crucial. This chart offers a decade-long glimpse into the Selling, General, and Administrative (SG&A) expenses of Teva Pharmaceutical Industries Limited and Bio-Techne Corporation, two industry giants. From 2014 to 2023, Bio-Techne's SG&A expenses surged by over 550%, reflecting its aggressive growth strategy. In contrast, Teva's expenses decreased by approximately 31%, indicating a strategic shift towards cost efficiency. Notably, Teva's expenses peaked in 2014, while Bio-Techne's reached their zenith in 2024. The data for 2024 is incomplete for Teva, highlighting potential reporting delays or strategic changes. This analysis underscores the dynamic nature of financial management in the healthcare sector, where companies must balance growth with fiscal prudence.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited and United Therapeutics Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Comparing SG&A Expenses: Bio-Techne Corporation vs Corcept Therapeutics Incorporated Trends and Insights